Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo. (HealthDay News) — For patients with heart failure with preserved ...

HFPEF, which accounts for approximately half of all heart failure cases, carries with it a significant morbidity and mortality burden. As with heart failure with reduced ejection fraction ...

On November 16, at the 100th American Heart Association (AHA) Scientific Sessions ... in patients with obesity and heart failure with preserved ejection fraction (HFpEF) on the major heart failure ...

AHA 2024 REALIZE ... get patients with heart failure on the right drugs at the right doses. Commentary, November 26, 2024 ESC 2024 Can You Deprescribe After Ejection Fraction Improvement?